Rankings
▼
Calendar
AUPH Q2 2016 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$55,000
Gross Profit
$54,000
98.2% margin
Operating Income
-$5M
-8276.4% margin
Net Income
-$3M
-5956.4% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
-3.5%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$150,000
Balance Sheet
Total Assets
$30M
Total Liabilities
$11M
Stockholders' Equity
$20M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q3 2016 →
